Prostate Cancer Trial, Recruiting (NCT05487846)

Prostate Cancer Trial, Recruiting NCT05487846 Sponsor: Thomas Jefferson University Condition: Prostate Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05487846 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Prostate Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are willing and able to sign and date a consent form agreeing to take part in the study
People who speak English
People who are willing to follow all study procedures and are available for the full duration of the study
People who are 18 years of age or older
African American men who meet at least one of the following conditions: have prostate cancer that has spread to other parts of the body; have a specific type of prostate cancer growth pattern called intraductal or ductal pathology; have a cancer stage classified as T3a or higher; have a cancer grade of group 4 or a Gleason score of 8 or higher; or have a family history of breast, ovarian, prostate, pancreatic, colorectal, or uterine cancer in 3 or more blood relatives, especially if those relatives were diagnosed before age 50

Who may not be able to join:

People who do not meet the conditions listed above
People under the age of 18
People who have difficulty understanding the consent form, or for whom significant anxiety is noticed during the consent process

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Amy Leader, DrPH, MPH, Thomas Jefferson University

Phone: 215-955-7739

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05487846

Sponsor: Thomas Jefferson University

Phase: Not Applicable

Status: Recruiting

Condition: Prostate Cancer

Trial contact: 215-955-7739

More information: https://clinicaltrials.gov/study/NCT05487846

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are willing and able to sign and date a consent form agreeing to take part in the study
People who speak English
People who are willing to follow all study procedures and are available for the full duration of the study
People who are 18 years of age or older
African American men who meet at least one of the following conditions: have prostate cancer that has spread to other parts of the body; have a specific type of prostate cancer growth pattern called intraductal or ductal pathology; have a cancer stage classified as T3a or higher; have a cancer grade of group 4 or a Gleason score of 8 or higher; or have a family history of breast, ovarian, prostate, pancreatic, colorectal, or uterine cancer in 3 or more blood relatives, especially if those relatives were diagnosed before age 50

Who may not be able to join:

People who do not meet the conditions listed above
People under the age of 18
People who have difficulty understanding the consent form, or for whom significant anxiety is noticed during the consent process

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Thomas Jefferson University

Registry

ClinicalTrials.gov

Start date

1 January 2025

Est. completion

1 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Frequency of pretest genetic counseling engagement

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov